1. Home
  2. EDAP vs ACOG Comparison

EDAP vs ACOG Comparison

Compare EDAP & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EDAP TMS S.A.

EDAP

EDAP TMS S.A.

HOLD

Current Price

$4.13

Market Cap

137.6M

Sector

Health Care

ML Signal

HOLD

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

HOLD

Current Price

$5.28

Market Cap

129.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
EDAP
ACOG
Founded
1979
2000
Country
France
Canada
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
137.6M
129.4M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
EDAP
ACOG
Price
$4.13
$5.28
Analyst Decision
Buy
Strong Buy
Analyst Count
3
1
Target Price
$8.50
$18.00
AVG Volume (30 Days)
76.0K
61.5K
Earning Date
11-06-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$74,853,925.00
$7,427,199.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.67
$132.35
P/E Ratio
N/A
N/A
Revenue Growth
0.61
N/A
52 Week Low
$1.21
$3.75
52 Week High
$4.29
$11.54

Technical Indicators

Market Signals
Indicator
EDAP
ACOG
Relative Strength Index (RSI) 66.29 37.16
Support Level $3.44 $5.20
Resistance Level $4.28 $5.97
Average True Range (ATR) 0.35 0.45
MACD -0.02 -0.06
Stochastic Oscillator 83.19 5.48

Price Performance

Historical Comparison
EDAP
ACOG

About EDAP EDAP TMS S.A.

Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: